Method for preparing nano liver-target biodegradating medicine carrier material

A carrier material and biodegradable technology, applied in the field of biomedical materials, to achieve good blood compatibility, good targeting ability, and improve the effect of treatment and quality of life
CN1743008AInactive Publication Date: 2006-03-08NANKAI UNIV

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
NANKAI UNIV
Publication Date
2006-03-08
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The preparation method includes the following steps: modifying hepatic target compound onto degradable polymer (chitosan, polylysine, glucosan, agar, polyglutamic acid-benzyl ester, polyalanine) with biological compatibility, and adopting ion exchange or ultrasonic emulsification process to obtain the invented nano hepatic target bio-degradable medicine carrier material. The hepatic target nano particle solution has good target performance for liver, the medicine enriched rate in the liver can be up to 75%, and its slowly-released administration can be up to above 15 days.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the field of biomedical materials, in particular to a method for preparing a nano liver-targeted biodegradation drug carrier material. Background technique

[0002] Liver cancer, especially primary liver cancer, is a common clinical disease and frequently-occurring disease. The mortality rate of primary liver cancer ranks third among malignant tumors, second only to gastric cancer and esophageal cancer. my country is an area with a high incidence of liver cancer, accounting for more than 50% of the global incidence. For the treatment of liver cancer, liver transplantation is the most recommended at present, but donors are hard to find. Anticancer drug therapy (cyclophosphamide, arabinothymidine hydrochloride) due to the systemic distribution of the drug, the drug concentration in the lesion is not high enough, but the damage to other organs is greater, and some patients often die from the damage of chemotherapy drugs to other...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More